101 related articles for article (PubMed ID: 45458)
21. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplant as a platform for tumor immunotherapy.
Fuchs EJ; Whartenby KA
Curr Opin Mol Ther; 2004 Feb; 6(1):48-53. PubMed ID: 15011781
[TBL] [Abstract][Full Text] [Related]
23. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
Ke X; Yang Y; Zhao X; Wang L
Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
[TBL] [Abstract][Full Text] [Related]
24. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
[TBL] [Abstract][Full Text] [Related]
25. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
26. Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation.
Rice A; Reiffers J; Bernard P; Fourès C; Bascans E; Lacombe F; Marit G; Broustet A
Nouv Rev Fr Hematol (1978); 1992; 34(2):167-74. PubMed ID: 1354352
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell transplantation activity in Europe 1999.
Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
[TBL] [Abstract][Full Text] [Related]
28. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
Vaughan WP
Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
[No Abstract] [Full Text] [Related]
29. [The transplantation of hemopoietic cells in patients with solid tumors].
Mikhaĭlova NB; Darskaia EI; Morozova EV; Shavva SA; Soldatenkov VE; Katyshev AV; Orlov AA; Platonova GG; Fregatova LM; Afanas'ev BV
Ter Arkh; 1998; 70(7):63-7. PubMed ID: 9742641
[TBL] [Abstract][Full Text] [Related]
30. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
31. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Passweg J; Baldomero H; Hermans J
Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
[TBL] [Abstract][Full Text] [Related]
32. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
Douay L
Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
[TBL] [Abstract][Full Text] [Related]
33. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
[TBL] [Abstract][Full Text] [Related]
34. [Autologous bone marrow grafts and solid tumors].
Beaulieu R
Union Med Can; 1983 May; 112(5):450-2, 460. PubMed ID: 6349082
[No Abstract] [Full Text] [Related]
35. [Autologous bone marrow transplantation].
Klingebiel T; Handgretinger R; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():42-5. PubMed ID: 7841780
[TBL] [Abstract][Full Text] [Related]
36. Activity survey and historical perspective of autologous stem cell transplantation in Europe.
Gratwohl A
Semin Hematol; 2007 Oct; 44(4):220-6. PubMed ID: 17961720
[TBL] [Abstract][Full Text] [Related]
37. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
38. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival.
Körbling M; Fliedner TM; Holle R; Magrin S; Baumann M; Holdermann E; Eberhardt K
Bone Marrow Transplant; 1991 May; 7(5):343-9. PubMed ID: 1676924
[TBL] [Abstract][Full Text] [Related]
39. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
Harada M
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial of intensive therapy and autologous bone marrow transplantation in the treatment of malignant diseases.
Harada M; Yoshida T; Funada H; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():543-52. PubMed ID: 6394815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]